Battery for assessment of neuropsychological status (RBANS) in schizophrenia: A pilot study in the Spanish population

Acta Neuropsychiatrica

Volumn 21, Issue 1, 2009, Pages 18-25

  Sanz, Juan C ^a,c   Vargas, Martín L ^b   Marín, Juan J ^a  

^a Psychiatric Hospital of Mérida   (Spain)

^b Hospital Provincial de Zamora   (Spain)

^c Hospital de Merida   (Spain)

Author keywords

Cognition disorders; Neuropsychological tests; Psychiatric diagnosis; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONCURRENT VALIDITY; CONTROLLED STUDY; CORRELATIONAL STUDY; CULTURAL FACTOR; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HUMAN; INTERRATER RELIABILITY; MALE; MEDICAL RESEARCH; NEUROPSYCHOLOGICAL TEST; PERFORMANCE; PILOT STUDY; POPULATION; SCHIZOPHRENIA;

EID: 61449260030     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2008.00341.x     Document Type: Article

References (29)

1. Sharma T, Antonove L. Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment. Psychiatr Clin North Am 2003 26 : 25 40.
2. Zakzanis K, Leach L, Kaplan E. Schizophrenia in neuropsychological differential diagnosis. Lisse : Sweets & Zetlinger b.v, 1999.
3. Hoff AL, Kremen WS. Neuropsychology in Schizophrenia: an update. Curr Opin Psychiatry 2003 16 : 149 155.
4. Sitskoorn MM, Aleman A, Ebisch SJH, Appels MCM, Kahn RS. Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophr Res 2004 71 : 285 295.
5. Spaulding WD, Fleming SK, Reed D, Sullivan M, Storzbach D, Lam M. Cognitive functioning in Schizophrenia: implications for psychiatric rehabilitation. Schizophr Bull 1999 25 : 275 289.
6. Goldberg TE. Towards brief assessment of cognitive function in clinical trials and practice. In : Keefe RSE, ed. Improving cognitive function in the schizophrenic patient. London : Science Press, 1999 : 44 50.
7. Randolph CH. Repeatable battery for the assessment of neuropsychological status. San Antonio : The Psychological Corporation, 1998.
8. Gold JN, Queern CQ, Iannone VN, Buchanan RW. Repeatable battery for the assessment of neuropsychological status as a screening test in Schizophrenia, I: sensitivity, reliability, and validity. Am J Psychiatry 1999 156 : 1944 1950.
9. Wilk CH, Gold JN, Humber K, Dickerson F, Fenton WS, Buchanan RW. Brief cognitive assessment in schizophrenia: normative data for the Repeatable battery for the assessment of neuropsychological status. Psychiatry Res 2004 70 : 175 186.
10. Loughland CM, Lewin TJ, Vaughan JC, Sheedy J, Harris AW. RBANS neuropsychological profiles within schizophrenia samples recruited from non-clinical settings. Schizophr Res 2007 89 : 234 242.
11. Holzer L, Chinet L, Jaugey L et al. Detection of cognitive impairment with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in adolescents with psychotic symptomatology. Schizophr Res 2007 95 : 48 53.
12. Randolph C, Tierney MD, Mohr E, Chase TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 1998 20 : 310 319.
13. Dickerson F, Boronow JJ, Stallings C, Origoni AE, Cole SK, Yolken RH. Cognitive functioning in schizophrenia and bipolar disorder: comparisons of performance on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Psychiatry Res 2004 129 : 45 53.
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC : American Psychiatric Association, 2000.
15. Muntal S, Dolors B, Zaragoza S, Aguilar M. RBANS-A: translation and adaptation form Spanish people. In : Haaland K, ed. Proceedings of the Thirty-Second Annual International Neuropsychological Society Conference. Baltimore, MD. New York : Cambridge University Press, 2004 : 86.
16. Kolb B, Whishaw IQ. Performance of schizophrenic patients on tests sensitive to left or right frontal, temporal, or parietal function in neurological patients. J Nerv Ment Dis 1983 171 : 435 443.
17. Golden CH. Stroop color and word test manual for clinical and experimental uses. Wood Dale : Stoelting Company, 1978.
18. Reitan RM. Manual for administration of neuropsychological tests batteries for adults and children. Tucson, AZ : Neuropsychology Press, 1979.
19. Benedet MJ, Alejandre MA. Tavec Test de Aprendizaje Verbal España - Complutense. Madrid : TEA Ediciones SA, 1988.
20. Rey A. L' examen clinique en psychologie, 2nd edn. Paris : Presses universitaires de France, 1964.
21. Weschsler D. WAIS-III administration and scoring manual. San Antonio, TX : Psychological Corporation, 1997.
22. Guy W. Early Clinical Drug Evaluation (ECDEU) assessment manual. Rockville : National Institute Mental Health, 1976.
23. Kay SR, Opler LA, Fiszbein A. Positive and negative syndrome scale (PANSS). Rating manual. New York : Albert Einstein College of Medicine, 1986.
24. Simpson GN, Angus JWS. A rating scale for extrapiramidal side effects. Acta Psychiatr Scand 1970 212 : 11 19.
25. Jolliffe J. Principal component analysis. New York : Springer-Verlag, 1986.
26. Hobart MP, Goldberg R, Bartko JJ, Gold JN. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic comparisons. Am J Psychiatry 1999 156 : 1951 1957.
27. Hughes C, Kumari V, Soni W et al. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Psychiatry Res 2002 59 : 137 146.
28. Green MF. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 2006 67 : 36 42 67.
29. Pino O, Guilera G, Gómez J, Rojo E, Vallejo J, Purdon SE. Escala breve para evaluar el deterioro cognitivo en pacientes psiquiátricos. Psicothema 2006 18 : 447 452.